MX2009011208A - Derivados de acido nicotinico como moduladores del receptor de glutamato metabotropico-5. - Google Patents
Derivados de acido nicotinico como moduladores del receptor de glutamato metabotropico-5.Info
- Publication number
- MX2009011208A MX2009011208A MX2009011208A MX2009011208A MX2009011208A MX 2009011208 A MX2009011208 A MX 2009011208A MX 2009011208 A MX2009011208 A MX 2009011208A MX 2009011208 A MX2009011208 A MX 2009011208A MX 2009011208 A MX2009011208 A MX 2009011208A
- Authority
- MX
- Mexico
- Prior art keywords
- modulators
- acid derivatives
- nicotinic acid
- glutamate receptor
- metabotropic glutamate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a novedosos derivados de bencimidazol, a su preparación, a su uso como productos farmacéuticos, y a composiciones farmacéuticas que los contienen, en donde los compuestos tienen la fórmula (I): en donde los sustituyentes son como se definen en la reivindicación 1, y sales, solvatos, hidratos y N-óxidos de los mismos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07106537 | 2007-04-19 | ||
PCT/EP2008/054682 WO2008128968A1 (en) | 2007-04-19 | 2008-04-17 | Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009011208A true MX2009011208A (es) | 2009-10-30 |
Family
ID=38654771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009011208A MX2009011208A (es) | 2007-04-19 | 2008-04-17 | Derivados de acido nicotinico como moduladores del receptor de glutamato metabotropico-5. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20090105266A1 (es) |
EP (1) | EP2146969A1 (es) |
JP (1) | JP2010524892A (es) |
KR (1) | KR20090130141A (es) |
CN (1) | CN101679299A (es) |
AR (1) | AR068072A1 (es) |
AU (1) | AU2008240790A1 (es) |
BR (1) | BRPI0810653A2 (es) |
CA (1) | CA2682676A1 (es) |
CL (1) | CL2008001114A1 (es) |
EA (1) | EA200901379A1 (es) |
MX (1) | MX2009011208A (es) |
PE (1) | PE20090074A1 (es) |
TW (1) | TW200904425A (es) |
WO (1) | WO2008128968A1 (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0606774D0 (en) * | 2006-04-03 | 2006-05-10 | Novartis Ag | Organic compounds |
WO2010135493A2 (en) * | 2009-05-20 | 2010-11-25 | Emory University | Alzheimer's disease imaging agents |
EP2390245A1 (en) * | 2010-05-26 | 2011-11-30 | Nabriva Therapeutics AG | Enantiomerically pure amines |
WO2012127393A1 (en) | 2011-03-18 | 2012-09-27 | Novartis Ag | COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS AND mGluR5 ANTAGONISTS FOR USE IN DOPAMINE INDUCED DYSKINESIA IN PARKINSON'S DISEASE |
JPWO2013081094A1 (ja) * | 2011-11-30 | 2015-04-27 | 東レ株式会社 | イミダゾ[1,2−a]ピリジン誘導体及びその医薬用途 |
EP2852586A1 (en) | 2012-03-16 | 2015-04-01 | Axikin Pharmaceuticals, Inc. | 3,5-diaminopyrazole kinase inhibitors |
US9186361B2 (en) | 2013-03-15 | 2015-11-17 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
US9233961B2 (en) | 2013-03-15 | 2016-01-12 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
HUE049733T2 (hu) | 2013-07-02 | 2020-10-28 | Syngenta Participations Ag | Növényvédõszerként aktív biciklusos vagy triciklusos heterociklusok kéntartalmú szubsztituensekkel |
NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
LT3083627T (lt) | 2013-12-19 | 2018-12-27 | Novartis Ag | [1,2,4]triazolo[1,5-a]pirimidino dariniai kaip protozoano proteasomos inhibitoriai, skirti parazitinių ligų tokių kaip leišmaniozė, gydymui |
CN107074846B (zh) | 2014-08-12 | 2020-05-19 | 先正达参股股份有限公司 | 具有含硫取代基的杀有害生物活性杂环衍生物 |
EP3230284B1 (en) | 2014-12-11 | 2020-04-15 | Syngenta Participations AG | Pesticidally active tetracyclic derivatives with sulfur containing substituents |
MY191736A (en) | 2014-12-23 | 2022-07-13 | Axikin Pharmaceuticals Inc | 3,5-diaminopyrazole kinase inhibitors |
EP3286186B1 (en) | 2015-04-24 | 2020-05-06 | Syngenta Participations AG | Pesticidally active polycyclic derivatives with sulfur substituted five membered ring heterocyles |
EP3656770A3 (en) | 2015-04-24 | 2020-09-09 | Syngenta Participations AG | Pesticidally active polycyclic derivatives with sulfur substituted five-membered ring heterocycles |
WO2017001314A1 (en) | 2015-07-01 | 2017-01-05 | Syngenta Participations Ag | Pesticidally active polycyclic derivatives with sulfur containing substituents |
BR112018000052A2 (pt) | 2015-07-01 | 2018-09-04 | Syngenta Participations Ag | derivados policíclicos ativos em termos pesticidas com substituintes contendo enxofre |
US11214565B2 (en) | 2015-11-20 | 2022-01-04 | Denali Therapeutics Inc. | Compound, compositions, and methods |
BR112018010347A2 (pt) | 2015-11-23 | 2018-12-04 | Syngenta Participations Ag | derivados heterocíclicos ativos em termos pesticidas com substituintes contendo enxofre e ciclopropila |
US11028080B2 (en) | 2016-03-11 | 2021-06-08 | Denali Therapeutics Inc. | Substituted pyrimidines as LRKK2 inhibitors |
CN114315819A (zh) | 2016-06-16 | 2022-04-12 | 戴纳立制药公司 | 作为用于治疗神经退化性病症的lrrk2抑制剂的嘧啶-2-基氨基-1h-吡唑 |
BR112019008492B1 (pt) | 2016-10-27 | 2024-01-30 | Syngenta Participations Ag | Compostos derivados heterocíclicos ativos em termos pesticidas com substituintes contendo enxofre e hidroxilamina, composição pesticida, método para controle de pragas e método para a proteção de material de propagação de plantas do ataque por pragas |
WO2018091389A1 (en) | 2016-11-17 | 2018-05-24 | Syngenta Participations Ag | Pesticidally active heterocyclic derivatives with sulphur containing substituents |
JP7113014B2 (ja) | 2016-12-15 | 2022-08-04 | シンジェンタ パーティシペーションズ アーゲー | 硫黄含有置換基を有する有害生物防除に活性な複素環式誘導体 |
RU2764666C2 (ru) | 2016-12-29 | 2022-01-19 | Селенити Терапьютикс (Бермуда), Лтд. | Соединения, ингибирующие металлоферменты |
WO2018125799A2 (en) | 2016-12-29 | 2018-07-05 | Viamet Pharmaceuticals (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
KR20240038149A (ko) | 2017-04-26 | 2024-03-22 | 바실리어 파마슈티카 인터내셔널 리미티드 | 푸라자노벤즈이미다졸 및 이의 결정 형태의 제조 공정 |
WO2018215304A1 (en) | 2017-05-22 | 2018-11-29 | Syngenta Participations Ag | Tetracyclic pyridazine sulphur containing compounds and their use as pesticides |
WO2019008072A1 (en) | 2017-07-05 | 2019-01-10 | Syngenta Participations Ag | HETEROCYCLIC DERIVATIVES HAVING PESTICIDE ACTIVITY HAVING SUBSTITUENTS CONTAINING SULFUR |
MX2020012502A (es) * | 2018-05-22 | 2021-02-15 | Nihon Nohyaku Co Ltd | Compuesto de benzimidazol o sal del mismo, agente insecticida y acaricida para la agricultura y horticultura que contiene dicho compuesto, y metodo para usar el mismo. |
AR115495A1 (es) | 2018-06-06 | 2021-01-27 | Syngenta Crop Protection Ag | Derivados heterocíclicos con sustituyentes que contienen azufre activos como plaguicidas |
AU2020247935A1 (en) * | 2019-03-25 | 2021-09-30 | The Trustees Of Columbia University In The City Of New York | Selective FOXO inhibitors for treatment of diabetes and other disorders related to impaired pancreatic function |
EA202192394A1 (ru) * | 2019-04-10 | 2022-01-24 | Селлестия Биотек Аг | Ингибиторы пути передачи сигнала notch и их применение для лечения рака |
US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
MX2023014032A (es) * | 2021-06-02 | 2023-12-15 | Nihon Nohyaku Co Ltd | Compuesto de bencimidazol o sal del mismo, agente de control de la filariasis canina que lo contiene y metodo de uso del mismo. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020198219A1 (en) * | 2000-08-08 | 2002-12-26 | Grant Elfrida R. | 2-pyridinamine compositions and related methods |
BR0208010A (pt) * | 2001-03-12 | 2004-12-21 | Avanir Pharmaceuticals | Composto de benzimidazol para modulação de ige e inibição de proliferação celular |
JP2006503038A (ja) * | 2002-09-13 | 2006-01-26 | メルク エンド カムパニー インコーポレーテッド | 融合ヘテロビシクロ置換フェニル代謝型グルタミン酸−5修飾因子 |
AU2005215379A1 (en) * | 2004-02-12 | 2005-09-01 | Merck & Co., Inc. | Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
CA2561718A1 (en) * | 2004-04-13 | 2005-10-27 | Icagen, Inc. | Polycyclic pyridines as potassium ion channel modulators |
-
2008
- 2008-04-17 MX MX2009011208A patent/MX2009011208A/es not_active Application Discontinuation
- 2008-04-17 KR KR1020097024024A patent/KR20090130141A/ko not_active Application Discontinuation
- 2008-04-17 CN CN200880017209A patent/CN101679299A/zh active Pending
- 2008-04-17 BR BRPI0810653-3A2A patent/BRPI0810653A2/pt not_active Application Discontinuation
- 2008-04-17 EA EA200901379A patent/EA200901379A1/ru unknown
- 2008-04-17 AU AU2008240790A patent/AU2008240790A1/en not_active Abandoned
- 2008-04-17 EP EP08736339A patent/EP2146969A1/en not_active Withdrawn
- 2008-04-17 PE PE2008000666A patent/PE20090074A1/es not_active Application Discontinuation
- 2008-04-17 CA CA002682676A patent/CA2682676A1/en not_active Abandoned
- 2008-04-17 WO PCT/EP2008/054682 patent/WO2008128968A1/en active Application Filing
- 2008-04-17 JP JP2010503503A patent/JP2010524892A/ja active Pending
- 2008-04-17 AR ARP080101578A patent/AR068072A1/es unknown
- 2008-04-18 CL CL2008001114A patent/CL2008001114A1/es unknown
- 2008-04-18 US US12/148,557 patent/US20090105266A1/en not_active Abandoned
- 2008-04-18 TW TW097114322A patent/TW200904425A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP2010524892A (ja) | 2010-07-22 |
PE20090074A1 (es) | 2009-03-02 |
AU2008240790A1 (en) | 2008-10-30 |
EA200901379A1 (ru) | 2010-04-30 |
CL2008001114A1 (es) | 2008-12-19 |
AR068072A1 (es) | 2009-11-04 |
BRPI0810653A2 (pt) | 2014-11-04 |
US20090105266A1 (en) | 2009-04-23 |
CA2682676A1 (en) | 2008-10-30 |
KR20090130141A (ko) | 2009-12-17 |
EP2146969A1 (en) | 2010-01-27 |
WO2008128968A1 (en) | 2008-10-30 |
CN101679299A (zh) | 2010-03-24 |
TW200904425A (en) | 2009-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009011208A (es) | Derivados de acido nicotinico como moduladores del receptor de glutamato metabotropico-5. | |
TW200732323A (en) | Organic compounds | |
MX2010001338A (es) | Derivados de pirimidina y piridina y su uso y composiciones farmaceuticas. | |
IN2014CN04127A (es) | ||
MX2009013078A (es) | Derivados de oxadiazol y su uso como potenciadores de los receptores metabotropicos de glutamato - 842. | |
UA85576C2 (ru) | Тетразольные соединения и их применение в качестве метаботропических антагонистов рецепторов глутамата | |
TW200604183A (en) | Triazole compounds and their use as metabotropic glutamate receptor antagonists | |
MX354102B (es) | Derivados de bencimidazol-prolina. | |
MX2011011661A (es) | Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750. | |
MX2009011816A (es) | Derivados de piridina. | |
MY148634A (en) | Pyridazinone derivatives | |
MX2021004000A (es) | Derivados de piperidina. | |
IL189987A0 (en) | Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists | |
EA201001683A1 (ru) | Производные фенил- или пиридинилзамещенных индазолов | |
TN2013000253A1 (en) | Bicyclo[3.2.1]octyl amide derivatives and uses of same | |
WO2009024611A3 (en) | 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use | |
MX2010003001A (es) | Derivados de quinolina como antagonistas del receptor de la 5-hidroxitriptamina 5a. | |
MY151986A (en) | Adamantyl diamide derivatives and uses of same | |
MX2010009022A (es) | Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso. | |
RS51661B (en) | NEW DIOSMETHINE DERIVATIVES, THE PROCEDURE FOR THEIR MAKING AND THE PHARMACEUTICAL MIXTURES CONTAINING THEM | |
TW200738653A (en) | Anthranilamide/2-amino-heteroarene carboxamide derivatives | |
EA201270428A1 (ru) | Замещенные n-фенил-1-(4-пиридинил)-1н-пиразол-3-амины | |
MX2012004835A (es) | Derivados de espirolactama y usos de los mismos. | |
MX2012002369A (es) | Formas de anhidrato de un derivado de piridina. | |
WO2009050197A3 (en) | Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |